Literature DB >> 9539708

Identification of a nucleotide binding site in HIV-1 integrase.

R R Drake1, N Neamati, H Hong, A A Pilon, P Sunthankar, S D Hume, G W Milne, Y Pommier.   

Abstract

HIV-1 integrase is essential for viral replication and can be inhibited by antiviral nucleotides. Photoaffinity labeling with the 3'-azido-3'-deoxythymidine (AZT) analog 3',5-diazido-2', 3'-dideoxyuridine 5'-monophosphate (5N3-AZTMP) and proteolytic mapping identified the amino acid 153-167 region of integrase as the site of photocrosslinking. Docking of 5N3-AZTMP revealed the possibility for strong hydrogen bonds between the inhibitor and lysines 156, 159, and 160 of the enzyme. Mutation of these residues reduced photocrosslinking selectively. This report elucidates the binding site of a nucleotide inhibitor of HIV-1 integrase, and possibly a component of the enzyme polynucleotide binding site.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9539708      PMCID: PMC22460          DOI: 10.1073/pnas.95.8.4170

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  31 in total

Review 1.  Genetics of retroviral integration.

Authors:  S P Goff
Journal:  Annu Rev Genet       Date:  1992       Impact factor: 16.830

2.  Human immunodeficiency virus integrase protein requires a subterminal position of its viral DNA recognition sequence for efficient cleavage.

Authors:  C Vink; D C van Gent; Y Elgersma; R H Plasterk
Journal:  J Virol       Date:  1991-09       Impact factor: 5.103

Review 3.  The retroviral enzymes.

Authors:  R A Katz; A M Skalka
Journal:  Annu Rev Biochem       Date:  1994       Impact factor: 23.643

Review 4.  Retroviral integrases and their cousins.

Authors:  P Rice; R Craigie; D R Davies
Journal:  Curr Opin Struct Biol       Date:  1996-02       Impact factor: 6.809

5.  Mapping features of HIV-1 integrase near selected sites on viral and target DNA molecules in an active enzyme-DNA complex by photo-cross-linking.

Authors:  T S Heuer; P O Brown
Journal:  Biochemistry       Date:  1997-09-02       Impact factor: 3.162

6.  Targeting retroviral integration.

Authors:  F Bushman
Journal:  Science       Date:  1995-03-10       Impact factor: 47.728

7.  Chemical trapping of ternary complexes of human immunodeficiency virus type 1 integrase, divalent metal, and DNA substrates containing an abasic site. Implications for the role of lysine 136 in DNA binding.

Authors:  A Mazumder; N Neamati; A A Pilon; S Sunder; Y Pommier
Journal:  J Biol Chem       Date:  1996-11-01       Impact factor: 5.157

8.  Proteolytic mapping of the thymidine/thymidylate binding site of herpes simplex virus type 1 thymidine kinase: a general photoaffinity labeling method for identifying active-site peptides.

Authors:  T M Rechtin; M E Black; R R Drake
Journal:  Anal Biochem       Date:  1996-05-15       Impact factor: 3.365

9.  Nucleotide binding by the HIV-1 integrase protein in vitro.

Authors:  J R Lipford; S T Worland; C M Farnet
Journal:  J Acquir Immune Defic Syndr (1988)       Date:  1994-12

10.  Synthesis of a photoaffinity analog of 3'-azidothymidine, 5-azido-3'-azido-2',3'-dideoxyuridine. Interactions with herpesvirus thymidine kinase and cellular enzymes.

Authors:  F Mao; T M Rechtin; R Jones; A A Cantu; L S Anderson; A Radominska; M P Moyer; R R Drake
Journal:  J Biol Chem       Date:  1995-06-09       Impact factor: 5.157

View more
  12 in total

1.  Discovery of a small-molecule HIV-1 integrase inhibitor-binding site.

Authors:  Laith Q Al-Mawsawi; Valery Fikkert; Raveendra Dayam; Myriam Witvrouw; Terrence R Burke; Christoph H Borchers; Nouri Neamati
Journal:  Proc Natl Acad Sci U S A       Date:  2006-06-19       Impact factor: 11.205

2.  Identification of amino acids in HIV-1 and avian sarcoma virus integrase subsites required for specific recognition of the long terminal repeat Ends.

Authors:  Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Biol Chem       Date:  2005-11-18       Impact factor: 5.157

3.  Human immunodeficiency virus type 1 cDNA integration: new aromatic hydroxylated inhibitors and studies of the inhibition mechanism.

Authors:  C M Farnet; B Wang; M Hansen; J R Lipford; L Zalkow; W E Robinson; J Siegel; F Bushman
Journal:  Antimicrob Agents Chemother       Date:  1998-09       Impact factor: 5.191

4.  Comparative docking and CoMFA analysis of curcumine derivatives as HIV-1 integrase inhibitors.

Authors:  Pawan Gupta; Prabha Garg; Nilanjan Roy
Journal:  Mol Divers       Date:  2011-02-15       Impact factor: 2.943

5.  Characterization of the HIV-1 integrase chromatin- and LEDGF/p75-binding abilities by mutagenic analysis within the catalytic core domain of integrase.

Authors:  Yingfeng Zheng; Zhujun Ao; Kallesh Danappa Jayappa; Xiaojian Yao
Journal:  Virol J       Date:  2010-03-23       Impact factor: 4.099

6.  Exploring the binding of HIV-1 integrase inhibitors by comparative residue interaction analysis (CoRIA).

Authors:  Devendra K Dhaked; Jitender Verma; Anil Saran; Evans C Coutinho
Journal:  J Mol Model       Date:  2008-12-02       Impact factor: 1.810

7.  Defining the DNA substrate binding sites on HIV-1 integrase.

Authors:  James Dolan; Aiping Chen; Irene T Weber; Robert W Harrison; Jonathan Leis
Journal:  J Mol Biol       Date:  2008-11-07       Impact factor: 5.469

Review 8.  HIV-1 IN inhibitors: 2010 update and perspectives.

Authors:  Christophe Marchand; Kasthuraiah Maddali; Mathieu Métifiot; Yves Pommier
Journal:  Curr Top Med Chem       Date:  2009       Impact factor: 3.295

9.  Specificity of LTR DNA recognition by a peptide mimicking the HIV-1 integrase {alpha}4 helix.

Authors:  Zeina Hobaika; Loussine Zargarian; Yves Boulard; Richard G Maroun; Olivier Mauffret; Serge Fermandjian
Journal:  Nucleic Acids Res       Date:  2009-12       Impact factor: 16.971

Review 10.  Integrase and integration: biochemical activities of HIV-1 integrase.

Authors:  Olivier Delelis; Kevin Carayon; Ali Saïb; Eric Deprez; Jean-François Mouscadet
Journal:  Retrovirology       Date:  2008-12-17       Impact factor: 4.602

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.